GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (FRA:BKD) » Definitions » Cyclically Adjusted Price-to-FCF

Bruker (FRA:BKD) Cyclically Adjusted Price-to-FCF : 61.89 (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Bruker Cyclically Adjusted Price-to-FCF?

As of today (2024-05-22), Bruker's current share price is €69.94. Bruker's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €1.13. Bruker's Cyclically Adjusted Price-to-FCF for today is 61.89.

The historical rank and industry rank for Bruker's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:BKD' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 33.02   Med: 52.32   Max: 98.24
Current: 61.99

During the past years, Bruker's highest Cyclically Adjusted Price-to-FCF was 98.24. The lowest was 33.02. And the median was 52.32.

FRA:BKD's Cyclically Adjusted Price-to-FCF is ranked worse than
67.11% of 228 companies
in the Medical Devices & Instruments industry
Industry Median: 44.93 vs FRA:BKD: 61.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bruker's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €0.003. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €1.13 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bruker Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bruker's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Cyclically Adjusted Price-to-FCF Chart

Bruker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.37 66.98 86.24 62.82 60.36

Bruker Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.15 61.72 52.01 60.36 76.22

Competitive Comparison of Bruker's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Bruker's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted Price-to-FCF falls into.



Bruker Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bruker's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=69.94/1.13
=61.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bruker's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.003/131.7762*131.7762
=0.003

Current CPI (Mar. 2024) = 131.7762.

Bruker Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.023 100.560 0.030
201409 0.016 100.428 0.021
201412 0.298 99.070 0.396
201503 0.116 99.621 0.153
201506 -0.048 100.684 -0.063
201509 0.236 100.392 0.310
201512 0.750 99.792 0.990
201603 -0.120 100.470 -0.157
201606 0.049 101.688 0.063
201609 0.150 101.861 0.194
201612 0.470 101.863 0.608
201703 0.123 102.862 0.158
201706 -0.149 103.349 -0.190
201709 0.133 104.136 0.168
201712 0.492 104.011 0.623
201803 0.182 105.290 0.228
201806 0.148 106.317 0.183
201809 0.088 106.507 0.109
201812 0.626 105.998 0.778
201903 0.020 107.251 0.025
201906 -0.042 108.070 -0.051
201909 0.211 108.329 0.257
201912 0.625 108.420 0.760
202003 0.026 108.902 0.031
202006 -0.049 108.767 -0.059
202009 0.357 109.815 0.428
202012 0.930 109.897 1.115
202103 0.402 111.754 0.474
202106 -0.004 114.631 -0.005
202109 0.042 115.734 0.048
202112 0.639 117.630 0.716
202203 0.353 121.301 0.383
202206 -0.393 125.017 -0.414
202209 0.080 125.227 0.084
202212 0.874 125.222 0.920
202303 0.395 127.348 0.409
202306 -0.066 128.729 -0.068
202309 0.109 129.860 0.111
202312 1.091 129.419 1.111
202403 0.003 131.776 0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bruker  (FRA:BKD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bruker Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bruker's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bruker (FRA:BKD) Business Description

Traded in Other Exchanges
Address
40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.